Press Releases
June 20, 2024
June 13, 2024
Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease
June 12, 2024
May 29, 2024
May 8, 2024
April 25, 2024
April 18, 2024
March 28, 2024
February 6, 2024
January 4, 2024